^
    Back
    Association details:
    Biomarker:ATRX mutation
    Cancer:Gastric Cancer
    Drug Class:Immunotherapy
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: C3 – Early Trials
    Source:
    BMC Cancer
    Title:

    The association of sex-biased ATRX mutation in female gastric cancer patients with enhanced immunotherapy-related anticancer immunity

    Published date:
    03/07/2021
    Excerpt:
    In the ICI-treated cohort from MSKCC, GC patients with ATRX mutation were associated with prolonged overall survival.
    DOI:
    10.1186/s12885-021-07978-3